CD44 and breast carcinoma: Additionally, the inhibition of the STAT3 pathway (through the selective blocking of STAT3 phosphorylation) was obtained with the combination of curcumin and epigallocatechin gallate in a pharmacological treatment, which reduced the CD44+ population of CSCs in MDA-MB-231 and MCF7 breast cancer cell lines (193).